<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular endothelial growth factor (VEGF) is a survival and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> factor that is a target for therapy in a variety of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In many <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, VEGF production is increased leading to cell survival responses </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we demonstrate that <z:chebi fb="0" ids="52288">lysophosphatidic acid</z:chebi> (<z:chebi fb="8" ids="52288">LPA</z:chebi>) induces <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of VEGF in the <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> cell line, U266, the Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, BJAB, and the <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL)-like cell line, I-83 </plain></SENT>
<SENT sid="3" pm="."><plain>This increase in <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of VEGF corresponded with increased luciferase activity of the VEGF promoter in BJAB and I-83 cells and increased protein levels in I-83 cells </plain></SENT>
<SENT sid="4" pm="."><plain>Secretion of VEGF was also increased in these cells following <z:chebi fb="8" ids="52288">LPA</z:chebi> treatment </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="8" ids="52288">LPA</z:chebi> treatment also caused the activation of both VEGFR1 and VEGFR2 </plain></SENT>
<SENT sid="6" pm="."><plain>The increase in VEGF expression by <z:chebi fb="8" ids="52288">LPA</z:chebi> is mediated by the activation of c-Jun N-terminal Kinase (JNK) and transcription factor NFkappaB since blocking JNK or NFkappaB activation inhibited <z:chebi fb="8" ids="52288">LPA</z:chebi> induced VEGF expression </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, we have demonstrated that <z:chebi fb="8" ids="52288">LPA</z:chebi> protects cells from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and blocking activation of both VEGFR1 and VEGFR2 using a VEGF receptor kinase inhibitor prevented <z:chebi fb="8" ids="52288">LPA</z:chebi> survival responses </plain></SENT>
<SENT sid="8" pm="."><plain>Knocking down expression of VEGFR1 and inhibiting activation of NFkappaB and JNK also blocked <z:chebi fb="8" ids="52288">LPA</z:chebi> induced protection against <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, this indicates that <z:chebi fb="8" ids="52288">LPA</z:chebi> contributes to VEGF production in B cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> leading to cell survival </plain></SENT>
</text></document>